Events

Conference: BORDERLESS BORDER MANAGEMENT 2025
MAR
Tue
04
MAR
Wed
05

Starts in 1 month from now

Location

Narva, Estonia

Programmes
Security

The Estonian Academy of Security Sciences invites you to a two-day international conference on border management. This event will bring together practitioners, academics, and business representatives to explore advancements and challenges in border security.

Topics covered in the conference:

  • Multifaceted Challenges in Security and Border Management
  • Research and Innovation for Border Management
  • Smart bots on the ground: education and Training
  • Innovative Border Technologies
  • Opportunities for Cross-Sectorial Cooperation

Practical information:

  • On-site event
  • Participation is free
  • Accommodation is not provided

For more information and registration, please visit the organiser’s page via this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.